ProQR is pioneering a next-generation RNA technology called Axiomer®, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unmet need.
Check out our vacancies. We are looking for people who are inspired by our mission to change the lives of patients and their loved ones and fit well with our collaborative, rigorous and entrepreneurial culture. Are you up for a challenge and do you want to become a ProQRian?
If you would like to join our team at ProQR but you can't find the right job opening at this moment, you're always welcome to send us an open application by filling out the application form.
What is RNA and how can we use the body's own RNA editing machinery to treat disease? Learn more about the Axiomer® RNA editing technology and how we are creating a new class of medicines.
